期刊文献+

通心络胶囊联合阿司匹林预防心房颤动患者脑栓塞的对照研究 被引量:2

A control study of tongxinluo capsule in combination with aspirin to prevent cerebra thromboembolism due to atrial fibrillation
下载PDF
导出
摘要 目的比较通心络胶囊联合阿司匹林、阿司匹林和华法林预防心房颤动(AF)患者脑栓塞的疗效和不良反应。方法AF患者450例,随机分为通心络胶囊联合阿司匹林组(A组)150例,予通心络胶囊0.52g,3次/日,阿司匹林300mg/d;华法林组(B组)150例,予华法林1.25~5.0mg/d,维持国际标准化比值1.8~2.5;阿司匹林组(C组)15O例,予阿司匹林300mg/d,所有患者均给予基础疾病治疗,随访2年,以脑栓塞发病率作为疗效判定依据。结果脑栓塞年发病率A组8.0%,B组4.0%(两组比较x^2=4.5455,P=0.0330),C组14.0%(与A组比较x^2=6.2937,p=0.0121)。华法林组有2例出现脑出血,1例出现上消化道出血,其余两组无出血副作用。结论通心络胶囊联合阿司匹林预防AF患者脑栓塞的效果不如华法林,优于单用阿司匹林,无严重不良反应发生、安全,且不需检测INR。 Objective To comparison of the efficacy and safety of usage of Tongxinluo capsule combination with Aspirin, Warfarin and Aspirin to prevent Cerebral thromboembolism due to atrial fibrillation(AF).Methods 450 patients with AF were divided into 3 groups randomly. Patients of Tongxinluo capsule combination with Aspirin grop(n = 150) were dispensed by Tongxinluo capsule(0. 52g/day) and Aspirin (0.3g/day).Patients of Warfarin group (n=150) were dispensed by Warfarin, The range of dosage was 1.25-5mg/day and Keep the INR between 1.8 and 2.5. Patients of Aspirin group(n=150) were dispensed by Aspirin (0.3g/day). The primary disease of all patients was intervention. Clinical prognosis of the three groups such as Cerebral tbromboembolism and side effect were followed up 2 years. Results The incidence rate of Cerebral thromboembolism in Tongxinluo capsule combination with Aspirin grop(8.0%/year) was difference than in Warfarin group(4.0%/year, x^2=4.5455, P=0.0330) and significantly lower than in aspirin grop(14.0%/year, x^2=6.2937,P=0.0121).The incidence rate of hemorrage in Warfarin group was 1.0%/year (n=3)and it was zero in the other two grops(x^2=1.3468, P=0.2458).Conelusion The effect of usage of Tongxinluo capsule combination with Aspirin to prevent Cerebral thromboembolism due to AF is no better than usage of Warfarin and significantly better than usage of Aspirin. lt is safe using Tongxinluo capsule combination with Aspirin to prevent Cerebral thromboembolism due to AF,and it does not need detect INR.
出处 《国际医药卫生导报》 2009年第1期56-59,共4页 International Medicine and Health Guidance News
关键词 通心络胶囊 华法林 阿司匹林 心房颤动 脑栓塞 Tongxinluo capsule Warfarin Aspirin Cerebral thromboembolism Atrial fibrillation
  • 相关文献

参考文献11

二级参考文献40

  • 1赵明中,高承梅,张宇洋.通心络胶囊对实验性心肌缺血再灌注损伤保护作用的实验研究[J].中国中医基础医学杂志,2000,6(1):36-38. 被引量:50
  • 2侯安会,徐淑文.水蛭的临床运用和实验研究概要[J].黑龙江中医药,1994,23(4):55-56. 被引量:15
  • 3王朋,张颖,范亚明,王绿娅,杜嘉会.水蛭、丹参对实验性动脉粥样硬化及纤溶系统的影响[J].心肺血管病杂志,1996,15(1):52-54. 被引量:60
  • 4[1]Conway DS,Pearce LA,Chin BS,Hart RG,Lip GY.Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation:relationnship to stroke risk factors[J].Circulation,2002,106(15):1962-7.
  • 5[2]Conway DS,Heeringa J,Van Der Kuip DA,Chin BS,Hofman A,Witteman JC,Lip Gy.Atrial fibrllation and the prothrombotic state in the elderly:the Rotterdamstudy[J].Stroke,2003,34(2):413-7.
  • 6[3]Li-Saw-Hee FL,Blann AD,Lip GY.A cross-sectinal and diurnal study of thrombogenesis among patients with chronic atrial fibrillation[J].Am Coll Cardiol,2000,35(7):1926-31.
  • 7[4]Goldsmith IR,Foo LS,Blann AD,Lip GY.Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty[J].Clin Cardiol,2000,23(8):587-90.
  • 8[5]Li-Saw-Hee FL,Blann AD,Edmunds E,Gibbs CR,Lip GY.Effect of acute exercise on the raised plasma fibrinogen,soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation[J].Clin Cardiol,2001,24(5):409-14.
  • 9[6]Li-Saw-Hee Fl,Blann AD,Gurney D,Lip GY.Plasma von Willebrand factor,fibrinogen and soluble P-selectin levels in paroxysmal,persistent and permanent atrial fibrillation.Effects of cardioversion and return of left atrial function[J].Eur Heart J,2001,22(18):1741-7.
  • 10[7]Mondillo S,Sabatini L,Agricola E,Ammaturo T,Guerrini F,Barbati R,Pastore M,Fineschi D,Nami R.Correlation between left atrial size,prothrombotic state and markers of endothelial dysfunction in patients with long chronic nonrheumatic atrial fibrillation[J].Int J Cardiol,2000.

共引文献785

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部